Last week’s settlement that would see Purdue Pharma and its owners, the Sackler family, pay $7.4 billion to resolve lawsuits ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in ...

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement aimed at resolving thousands of lawsuits connected to the company’s role in the opioid crisis. The agreement ...

The Sackler family and Purdue Pharma have agreed to a combined $7.4 billion settlement, according to the Utah Department of Commerce. Utah’s share would be $57 million of it if the state agrees ...

Bankrupt Purdue Pharma and its owners have agreed to pay ... members of the billionaire Sackler family, from any further litigation related to the addiction crisis. Thursday’s settlement in ...

The deal would also end the Sacklers’ control of Purdue. The fate of the company itself, which remains in Chapter 11 bankruptcy since filing in 2019, will be determined by a board of trustees ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the prescription ...

The Sacklers and Purdue Pharma boosted their settlement contribution to $7.4 billion after the U.S. Supreme Court overturned a prior settlement in June 2024. If approved, the new plan would end ...